Funding Round
Cala Health Secures $50M Growth Capital for Tremor Therapy
Cure Medtech Funding Tracker4/20/2026ยท04/20/26๐ USA
Summary
Cala Health secured $50M in growth capital to support commercial expansion of its FDA-cleared wearable tremor therapy, kIQ System.
Why it matters
Cala Health's $50M growth round cements its position as the market leader in wearable neuromodulation for essential tremor, with a commercially approved product already reimbursed by major insurers. The capital supports international expansion and next-generation device development.
#BCI#Neural Interfaces#Neurostimulation#Wearables
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items โ updated daily.
Start free trialAlready a member? Sign in